DRIEHAUS CAPITAL MANAGEMENT LLC 13D and 13G filings for DICE Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-11-10 09:23 am Sale |
2022-10-31 | 13G | DICE Therapeutics, Inc. DICE |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,915,496 4.020% |
-231,146 (-10.77%) |
Filing |
| 2022-02-14 09:24 am Purchase |
2021-12-31 | 13G | DICE Therapeutics, Inc. DICE |
DRIEHAUS CAPITAL MANAGEMENT LLC | 2,146,642 5.610% |
2,146,642 (New Position) |
Filing |